Comparable stake leader
CADIAN CAPITAL MANAGEMENT, LP
SEC ownership of Cryoport, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001124524.
Disclosed value leader
CADIAN CAPITAL MANAGEMENT, LP
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Symbol
- CYRX on Nasdaq
- SEC evidence covered
- 13F and 13D/G
- Largest SEC-reported holder
- CADIAN CAPITAL MANAGEMENT, LP
- Latest 13D/G holder
- CADIAN CAPITAL MANAGEMENT, LP
- Latest parsed evidence date
- 31 Mar 2026
- CIK
- 0001124524
- Location
- Brentwood, TN
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Issuer
Who this page is about.
2 identity fields
Ownership snapshot
Top shareholders of Cryoport, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CADIAN CAPITAL MANAGEMENT...
Disclosed value leader
CADIAN CAPITAL MANAGEMENT...
Comparable rows
50/50
Latest evidence
31 Mar 2026
13F
13D/G
Lead comparable stake: 10%
13D/G row: CADIAN CAPITAL MANAGEMENT, LP
Showing 1-8 of 50 holder rows.
Quick read
CADIAN CAPITAL MANAGEMENT, LP leads the comparable SEC ownership view at 10%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CADIAN CAPITAL MANAGEMENT, LP's linked filing trail.
Comparable ownership
Top 5
CADIAN CAPITAL MANAGEMENT, LP
10%
INTEGRATED CORE STRATEGIES (US) LLC
6.5%
ALGER ASSOCIATES INC
4.7%
BROWN CAPITAL MANAGEMENT LLC
2.2%
MORGAN STANLEY
9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CADIAN CAPITAL MANAGEMENT, LP |
13F
13D/G
Company
|
10%
from 13D/G
|
$39,548,120
4,776,343 shares
|
— | 31 Mar 2026 |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
Millennium Management LLC
|
6.5%
|
$31,150,099
3,244,802 shares
|
+$6,548,016 | 31 Dec 2025 |
| ALGER ASSOCIATES INC |
13D/G
|
4.7%
|
$17,597,692
2,358,940 shares
|
-$1,293,728 | 30 Jun 2025 |
| BROWN CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
2.2%
|
$10,638,091
1,112,771 shares
|
-$14,426,738 | 31 Dec 2025 |
| MORGAN STANLEY |
13F
Company
|
9%
|
$37,895,324
4,576,730 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
7.9%
|
$32,961,835
3,980,898 shares
|
— | 31 Mar 2026 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
5.9%
|
$24,595,442
2,970,464 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
4.2%
|
$17,544,128
2,118,856 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$4,214,184.
Buys
$0
Insiders: 0
Sells
$4,214,184
Insiders: 6
Net
-$4,214,184
Shares: -588,756
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 588,756
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 59,939 | $0 | $471,257 | -$471,257 |
| 3-6 | 0 | 11,570 | $0 | $115,540 | -$115,540 |
| 6-9 | 0 | 25,000 | $0 | $242,738 | -$242,738 |
| 9-12 | 0 | 492,247 | $0 | $3,384,649 | -$3,384,649 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-11 of 11 reporting-owner rows connected to Cryoport, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
11
Largest Forms 3/4/5 holder
Jerrell Shelton
Net 12M change
-$4,214,184
Latest report
21 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jerrell Shelton | President, CEO, Director | $10,189,483 | -$2,492,164 | -20% | Median | 21 Apr 2026 |
| Robert Stefanovich | Chief Financial Officer | $2,284,485 | -$411,896 | -15% | Filing P/S | 23 Mar 2026 |
| Richard J. Berman | Director | $1,513,319 | Mixed | 17 May 2024 | ||
| Edward J. Zecchini | Chief Digital and Technology Officer | $877,752 | -$368,630 | -30% | Filing P/S | 14 Mar 2026 |
| Mark W. Sawicki | Chief Scientific Officer | $837,272 | -$36,849 | -4.2% | Filing P/S | 23 Mar 2026 |
| Ramkumar Mandalam | Director | $806,465 | -$618,907 | -43% | Filing P/S | 10 Dec 2025 |
| Robert J. Hariri | Director | $497,854 | -$285,738 | -36% | Filing P/S | 11 Sep 2025 |
| Daniel M. Hancock | Director | $320,512 | Mixed | 06 Jun 2025 | ||
| Linda Baddour | Director | $315,309 | Mixed | 06 Jun 2025 | ||
| Blackstone Freeze Parent L.P. | 10%+ Owner | $174,626 | Mixed | 16 Nov 2021 | ||
| Blackstone Holdings II L.P. | 10%+ Owner | $174,626 | Mixed | 16 Nov 2021 |
Recent insider transactions for Cryoport, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 9.23% | 104,007 | 1,230,614 | 21 Apr 2026 | Direct | ||
| Jerrell Shelton | CYRX | Options to purchase common stock | Options Exercise | -100% | -104,007 | 0 | 21 Apr 2026 | Direct | ||
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 4.64% | 50,000 | 1,126,607 | 06 Apr 2026 | Direct | ||
| Jerrell Shelton | CYRX | Options to purchase common stock | Options Exercise | -32.5% | -50,000 | 104,007 | 06 Apr 2026 | Direct | ||
| Robert Stefanovich | CYRX | Common Stock | Sale | -0.39% | $8,949 | $8.18 | -1,094 | 279,277 | 23 Mar 2026 | Direct |
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 2.38% | 25,000 | 1,076,607 | 23 Mar 2026 | Direct | ||
| Jerrell Shelton | CYRX | Common Stock | Sale | -0.27% | $23,673 | $8.18 | -2,894 | 1,051,607 | 23 Mar 2026 | Direct |
| Jerrell Shelton | CYRX | Options to purchase common stock | Options Exercise | -14% | -25,000 | 154,007 | 23 Mar 2026 | Direct | ||
| Mark W. Sawicki | CYRX | Common Stock | Sale | -1.29% | $10,969 | $8.18 | -1,341 | 102,356 | 23 Mar 2026 | Direct |
| Edward J. Zecchini | CYRX | Common Stock | Sale | -1.8% | $16,112 | $8.00 | -2,014 | 109,719 | 16 Mar 2026 | Direct |
| Jerrell Shelton | CYRX | Common Stock | Sale | -0.75% | $63,344 | $8.00 | -7,918 | 1,054,501 | 16 Mar 2026 | Direct |
| Mark W. Sawicki | CYRX | Common Stock | Sale | -3.03% | $25,880 | $8.00 | -3,235 | 103,697 | 16 Mar 2026 | Direct |
| Robert Stefanovich | CYRX | Common Stock | Sale | -0.97% | $21,944 | $8.00 | -2,743 | 280,371 | 16 Mar 2026 | Direct |
| Edward J. Zecchini | CYRX | Common Stock | Award | 23.6% | 21,322 | 111,733 | 14 Mar 2026 | Direct | ||
| Edward J. Zecchini | CYRX | Stock Option (right to buy) | Award | 63,965 | 63,965 | 14 Mar 2026 | Direct | |||
| Jerrell Shelton | CYRX | Stock Option (right to buy) | Award | 492,901 | 492,901 | 14 Mar 2026 | Direct | |||
| Mark W. Sawicki | CYRX | Common Stock | Award | 27.2% | 22,845 | 106,932 | 14 Mar 2026 | Direct | ||
| Mark W. Sawicki | CYRX | Stock Option (right to buy) | Award | 68,534 | 68,534 | 14 Mar 2026 | Direct | |||
| Robert Stefanovich | CYRX | Common Stock | Award | 10.7% | 27,413 | 283,114 | 14 Mar 2026 | Direct | ||
| Robert Stefanovich | CYRX | Stock Option (right to buy) | Award | 82,240 | 82,240 | 14 Mar 2026 | Direct | |||
| Robert Stefanovich | CYRX | Common Stock | Sale | -13.2% | $300,386 | $7.76 | -38,700 | 255,701 | 12 Mar 2026 | Direct |
| Robert Stefanovich | CYRX | Common Stock | Options Exercise | 42.1% | 87,188 | 294,401 | 12 Mar 2026 | Direct | ||
| Robert Stefanovich | CYRX | Options to purchase common stock | Options Exercise | -100% | -87,188 | 0 | 12 Mar 2026 | Direct | ||
| Ramkumar Mandalam | CYRX | Common Stock | Sale | -12.5% | $115,540 | $9.99 | -11,570 | 80,758 | 10 Dec 2025 | Direct |
| Robert J. Hariri | CYRX | Common Stock | Sale | -32.8% | $242,738 | $9.71 | -25,000 | 51,275 | 11 Sep 2025 | Direct |
| Robert J. Hariri | CYRX | Common Stock | Options Exercise | 190.3% | 50,000 | 76,275 | 11 Sep 2025 | Direct | ||
| Robert J. Hariri | CYRX | Stock Option (right to buy) | Options Exercise | -100% | -50,000 | 0 | 11 Sep 2025 | Direct | ||
| Robert J. Hariri | CYRX | Common Stock | Sale | -16% | $43,000 | $8.60 | -5,000 | 26,275 | 22 Aug 2025 | Direct |
| Robert Stefanovich | CYRX | Common Stock | Sale | -4.3% | $80,618 | $8.67 | -9,300 | 207,213 | 19 Aug 2025 | Direct |
| Robert Stefanovich | CYRX | Common Stock | Options Exercise | 13.8% | 26,164 | 216,513 | 19 Aug 2025 | Direct | ||
| Robert Stefanovich | CYRX | Options to purchase common stock | Options Exercise | -100% | -26,164 | 0 | 19 Aug 2025 | Direct | ||
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 2.41% | 25,000 | 1,062,419 | 13 Aug 2025 | Direct | ||
| Jerrell Shelton | CYRX | Stock Option (right to buy) | Options Exercise | -100% | -25,000 | 0 | 13 Aug 2025 | Direct | ||
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 2.47% | 25,000 | 1,037,419 | 31 Jul 2025 | Direct | ||
| Jerrell Shelton | CYRX | Stock Option (right to buy) | Options Exercise | -50% | -25,000 | 25,000 | 31 Jul 2025 | Direct | ||
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 2.53% | 25,000 | 1,012,419 | 24 Jul 2025 | Direct | ||
| Jerrell Shelton | CYRX | Stock Option (right to buy) | Options Exercise | -33.3% | -25,000 | 50,000 | 24 Jul 2025 | Direct | ||
| Ramkumar Mandalam | CYRX | Common Stock | Sale | -30.6% | $294,899 | $7.24 | -40,728 | 92,328 | 22 Jul 2025 | Direct |
| Ramkumar Mandalam | CYRX | Common Stock | Options Exercise | 82.1% | 60,000 | 133,056 | 22 Jul 2025 | Direct | ||
| Ramkumar Mandalam | CYRX | Stock Option (right to buy) | Options Exercise | -100% | -60,000 | 0 | 22 Jul 2025 | Direct | ||
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 2.6% | 25,000 | 987,419 | 18 Jul 2025 | Direct | ||
| Jerrell Shelton | CYRX | Stock Option (right to buy) | Options Exercise | -25% | -25,000 | 75,000 | 18 Jul 2025 | Direct | ||
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 2.67% | 25,000 | 962,419 | 08 Jul 2025 | Direct | ||
| Jerrell Shelton | CYRX | Stock Option (right to buy) | Options Exercise | -20% | -25,000 | 100,000 | 08 Jul 2025 | Direct | ||
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 2.74% | 25,000 | 937,419 | 25 Jun 2025 | Direct | ||
| Jerrell Shelton | CYRX | Stock Option (right to buy) | Options Exercise | -16.7% | -25,000 | 125,000 | 25 Jun 2025 | Direct | ||
| Jerrell Shelton | CYRX | Common Stock | Sale | -1.76% | $115,366 | $7.06 | -16,344 | 912,419 | 24 Jun 2025 | Direct |
| Jerrell Shelton | CYRX | Common Stock | Options Exercise | 1.79% | 16,344 | 928,763 | 24 Jun 2025 | Direct | ||
| Jerrell Shelton | CYRX | Stock Option (right to buy) | Options Exercise | -9.83% | -16,344 | 150,000 | 24 Jun 2025 | Direct | ||
| Ramkumar Mandalam | CYRX | Common Stock | Sale | -15.4% | $93,447 | $7.02 | -13,321 | 73,056 | 24 Jun 2025 | Direct |
* marks a reported price that did not pass the local price check.